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Abstract 
BACKGROUND: Acute kidney injury is a severe clinical condition. It is common in neonates in intensive care unit. 
It is defined as a sudden deterioration in kidney function resulting in derangements in fluid balance, electrolytes, 
and waste products. The score for neonatal acute physiology perinatal extension in critically sick neonates with 
kidney injury is a useful tool for assessing the severity of the disease. 
AIM: This study aimed to determine the incidence of AKI and the role of SNAPPE 2 score in predicting mortality 
and morbidity of kidney injury in neonates. 
METHODS: The study was designed as a prospective clinical investigation performed in the period of three years, 
which included 100 neonates (50 with AKI and 50 without AKI) hospitalised in intensive care unit of University 
Clinic of Children Diseases in Skopje. The severity of the illness of hospitalised newborn infants was estimated 
with SNAPPE 2 score realised in the first 12 hours of admission to NICU. Medical data records of admitted 
neonates with AKI were analysed. The material was statistically processed using methods of descriptive statistics.  
RESULTS: During the study period, 770 new born's were hospitalised in the intensive care unit due to various 
pathological conditions and 50 new born's were selected with AKI. The control group consisted of 50 neonates 
with comparable associated pathological conditions, but without kidney injury. The calculated prevalence of AKI in 
neonates was 6.4%. Most of the involved neonates in the study in both groups (AKI and non-AKI) were born at 
term (64% and 54%) with a predominance of male neonates (68% and 60%). The mortality rate was significantly 
higher in newborns with AKI than in the control group (36% vs 24%) (p < 0.01). The mean SNAPPE 2 score value 
in neonates with AKI was higher than in the control group (58.72 vs 40.0), and the difference was significant (p = 
0.00001). Difficult score level predominated in half (50%) of newborn infants with AKI, while median score level 
predominated in control group (42%). There was a significant difference between the mean score value in 
neonates with AKI and lethal outcome compared to neonates with AKI without lethal outcome (70.73 ± 18.6 vs 
40.2 ± 16.6) (p < 0.0001).  
CONCLUSION: Acute kidney injury is a life-threatening condition with still high mortality rate. The severity of the 
illness of hospitalised neonates in an intensive care unit is estimated by SNAPPE 2 score. Also, the risk of 
mortality is estimated too, taking into consideration the fact that higher values of the score are associated with 
higher mortality. Appropriate treatment of neonates with severe kidney injury improves the outcome and reduces 
the mortality of the disease. 
 
 
 
Introduction 
 
Acute kidney injury (AKI) is a severe clinical 
condition. It is common in neonates in an intensive 
care unit (NICU). It is defined as a sudden 
deterioration in kidney function resulting in 
derangements in fluid balance, electrolytes, and waste 
products.  
The diagnosis of AKI is based on a rise of 
serum creatinine (sCr) and urine output of fewer than 
1.0 ml/kg/h. Serum creatinine has different value in 
neonates because of the presence of maternal 
creatinine, lower glomerular filtration rate (GFR) and 
differences in maturation [1], [2], [3], [4], [5], [6], [7], 
[8]. 
The incidence of kidney injury in children is 
significantly lower than in adults except in neonates 
where it occurs in 8 to 24% with mortality rates 
between 10% and 61% [9], [10]. 
Predisposing factors associated with acute 
kidney injury in neonates are certain clinical conditions 
such as asphyxia, sepsis, prematurity, meconium 
plaque syndrome, congenital heart diseases, invasive 
procedures and some nephrotoxic drugs. Appropriate 
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treatment of associated comorbidities, limited use of 
nephrotoxic drugs reduces the risk of kidney injury in 
neonates hospitalised in the intensive care unit [8], [9], 
[10], [11], [12]. 
The scoring system in critically sick neonates 
with kidney injury is used as a tool for predicting 
morbidity and mortality of the disease. It assesses the 
severity of the disease concerning the levels of 
deviation from normal physiology through the 
evaluation of numerous physical and laboratory tests. 
The most commonly used scoring system is Score for 
Neonatal Acute Physiology Perinatal Extension II 
(SNAPPE 2 score). It can predict the outcomes in 
critically ill newborns. It was developed by Ridsrtson in 
1993 as an index for the severity of the disease. It is 
performed within the first 24 hours of admission of 
newborns to NICU and contains 34 clinical tests and 
vital signs. In 2001 Rittersson simplified the score by 
creating a second generation of SNAPPE 2 score 
containing 6 physiological parameters and 3 
parameters for assessing perinatal mortality [13]. 
SNAPPE 2 is a useful tool for assessing the 
severity of the disease that correlates with neonatal 
mortality in intensive care units. A higher level than 40 
is associated with a higher mortality rate. The 
parameters associated with perfusion as a mean 
arterial pressure and acidosis are significantly 
associated with greater organ dysfunction and higher 
mortality [14], [15], [16]. 
This study aimed to determine the incidence 
of AKI and the role of SNAPPE 2 score in predicting 
mortality and morbidity of kidney injury in neonates. 
 
 
Methods 
 
The study was designed as a prospective, 
clinical, epidemiological investigation performed in 
three years, which included 100 neonates (50 with 
AKI and 50 without AKI) hospitalised in NICU of 
University Clinic of Children Diseases in Skopje. 
Criteria for inclusion in the study were: 
neonates up to 28 days of postnatal age; neonates 
treated in NICU due to certain pathological condition 
with or without the development of kidney injury. AKI 
was defined by elevated serum creatinine (> 130 
mol/L in neonates younger than 33 weeks and > 90 
mol/L in neonates older than 33 weeks) and the 
presence of oliguria (less than 1.0 ml/kg/h). According 
to our criteria, all neonates who were older than 28 
days of age, who had less than 24 hours of 
hospitalisation and neonates who had cardio-surgical 
interventions were excluded from the study. 
 
Medical data records of admitted neonates 
with AKI were analysed. The neonates were analyzed 
according to gender, birth weight, and gestational age. 
The laboratory examinations of serum creatinine 
values were done in the biochemical laboratory of the 
Clinic of Children Diseases using Kodak camera dry 
biochemistry. The severity of the illness of 
hospitalised neonates was estimated with SNAPPE 2 
score realised in the first 12 hours of hospitalisation to 
NICU. Also, the risk of mortality was estimated, taking 
into account the fact that higher values of the score 
are associated with a higher mortality rate. Table 1 
shows the examined variables in SNAPPE 2 score.  
Table 1: Score systems in NICU 
SNAPPE SNAPPE 2 
arterial pressure 
cardiac frequency 
respiratory rate 
temperature 
PCO2 
PO2 / FiO2 
PCO2 
leukocytes 
platelets 
urea in serum 
creatinine in serum 
diuresis 24 hours 
indirect bilirubin 
direct bilirubin 
sodium in serum 
potassium in serum 
calcium total 
calcium ionizing 
glycemia 
bicarbonate 
Ph. Blood 
convulsions 
apnea 
mean arterial pressure 
temperature 
pO2 / FiO2 
Ph. Blood 
convulsions 
diuresis 
 
 
The material was statistically analysed using 
the methods of descriptive statistics. To determine the 
significance of differences in the parameters, the tests 
for independent samples were analysed. Statistical 
significance was determined for the values of p < 
0.05. 
 
 
Results 
 
During the study period, 770 newborns were 
hospitalised in NICU due to various pathological 
conditions and 50 newborns were selected with AKI. 
The control group consisted of 50 neonates with 
comparable associated pathological conditions, but 
without kidney injury. The calculated prevalence of 
AKI in neonates was 6.4%. The mean gestational age 
of newborns with AKI was 37.42 ± 3.1 weeks and 
36.26 ± 3.8 weeks in the control group. The mean 
birth weight of neonates with AKI was 2890.8 ± 898.1 
grams, while in the control group was 2699.4 ± 894.6 
grams.  
Most of the involved neonates in both groups 
were born at term (64% and 54%) with a 
predominance of male (68% and 60%). Figure 1 and 
figure 2 show the distribution of neonates with AKI 
and non-AKI depending on age and gender. 
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Figure 1: Distribution of newborns with AKI and Non-AKI depending 
on age 
 
According to the outcomes of the disease, 18 
neonates with AKI and 12 neonates of the control 
group had a lethal outcome. So, the mortality rate in 
neonates with AKI was 36%, while 24% in the control 
group. This difference was not statistically significant 
(p < 0.01). 
 
Figure 2: Distribution of newborns with AKI and Non-AKI depending 
on gender 
 
All neonates were evaluated by SNAPPE 2 
score within the first 12 hours of admission in the 
intensive care unit. The score values were analysed in 
4 categories: light (score 1-20), medium (score 21-
40), difficult (41-70) and very difficult (over 70). The 
results showed that the mean score value in neonates 
with AKI was 58.72 ± 20.4, while 40.0 ± 20.0 in the 
control group. The difference of 18.72 between AKI 
group and control group was confirmed as significant 
(p = 0.00001) (Table 2). 
Table 2: Distribution of SNAPPE 2 score values in neonates in 
NICU  
 AKI Non-AKI  
T = 4.6 
P = 0.0000001 
Mean ± SD 58.72 ± 20.4 40.0 ± 20.0 
Min 29 8 
Max 97 78 
 
Table 3 shows the distribution of neonates 
with AKI depending on score levels compared to the 
control group. In half (50%) of neonates with AKI 
predominate difficult score level, while the median 
score level predominated in 42% neonates of the 
control group. 
 
 
Table 3: Distribution of neonates with AKI depending on score 
levels compared to the control group 
Score AKI / Non-AKI Mean ± SD Min-Max 
Light 
AKI N = 0 
Non-AKI N = 8 
0 
14.0 ± 3.9 
0 
8-19 
Medium 
AKI N = 10 
Non-AKI N = 21 
33.8 ± 3.3 
28.7 ± 4.8 
29-38 
22-39 
Difficult 
AKI N = 25 
Non-AKI N = 16 
52.24 ± 7 
43.18 ± 5.8 
42-67 
38-52 
Very difficult 
AKI N = 15 
Non-AK N = 5 
86.13 ± 8.3 
81.6 ± 8.3 
77-97 
72-91 
  
There was a significant difference between 
the mean score value in neonates with AKI and lethal 
outcome compared to newborn infants with AKI 
without lethal outcome (70.73 ± 18.6 vs 40.2 ± 16.6) 
(p < 0.0001) (Figure 3). 
 
Figure 3: Distribution of mean score values in neonates with AKI 
and lethal outcome and neonates with AKI without lethal outcome  
 
Figure 4 shows the distribution of score 
values in neonates compared to control group, 
depending on lethal outcomes. 66% of neonates with 
AKI and lethal outcome had a very difficult score level, 
as opposed to 59% survived neonates with AKI who 
had a lower score level. Compared to the control 
group, 54% neonates with lethal outcome had a 
difficult score level, and 51% of survived neonates 
had a medium score level.  
 
Figure 4: Distribution of score values in neonates with AKI 
compared to control group, depending on lethal outcomes 
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Discussion  
 
This study presents a clinical, epidemiological 
study that evaluated neonates who were treated in 
intensive care at the Universiti Clinic of Children 
Diseases. During the period of three years, a high 
number of neonates with various pathological 
conditions and AKI were hospitalised. But this study 
included 50 neonates with documented kidney injury, 
as well as other 50 neonates, as a control group, with 
comparable associated pathological conditions, but 
without kidney injury. The calculated prevalence of 
kidney injury in neonates was 6.4% [16], [17]. 
This data correlates with data presented in 
the literature, where the incidence of AKI in neonates 
has the highest rate (6-24%) compared to other age 
groups (infants, children and adults). The occurrence 
of AKI in neonates is influenced by various factors, 
such as gestational age, birth weight and co-morbid 
conditions present during and immediately after birth. 
A similar finding as in our study has been published in 
other studies done in various neonatal centres. In the 
study of Vachvanichsanong et al., the incidence of 
kidney injury in newborn infants was 6.3%, while in 
Bolat et al., and Stapleton et al., it was 8% and 8.4%, 
respectively [17], [18], [19], [20], [21], [22], [23], [24], 
[25], [26], [27], [28], [29]. 
 However, there are opposite findings. Thus, 
in the study of Momtaz et al., the incidence of kidney 
injury was 1.5%; in the studies of Mortazavi et al., 
2.7%; in Agras et al., 3.4%, and in the Mohkam et al., 
3.2%. We assume that these differences can be due 
to differences in the criteria for diagnosing AKI in 
neonates [30]. 
According to the sex distribution, for all 
gestational ages, in both groups of neonates (with AKI 
and control group), the majority of neonates were 
male (68% and 60%). A different finding was 
presented in the study of Momtaz et al., where female 
predominated in 87.7% of cases [21], [22], [23], [24]. 
According to the distribution of gestational 
age, the majority of neonates in both groups were 
term neonates (64% and 54%). The mean gestational 
age of neonates with AKI was 37.42 ± 3.1 weeks of 
gestation and the control group 36.26 ± 3.8 weeks of 
gestation. The mean birth weight of neonates with AKI 
was 2890.8 ± 898.1 grams and of the control group 
2699.4 ± 894.6 grams. In both groups, predominated 
neonates with a birth weight over 2500 grams (64% 
and 54%, respectively). 
There were no significant differences in the 
mortality rate in both groups of neonates (36% vs 
24%). This finding of 36% of mortality in neonates with 
AKI correlates to the data presented in the study of 
Gharehbaghi et al. In our study, the mortality was 
significantly higher in neonates with AKI and 
congenital heart disease as comorbidity, and they 
underwent invasive therapeutic procedures (umbilical 
catheterisation and assisted ventilation). Special 
attention needs to be paid in the application of 
invasive procedures in neonates due to the 
association of these procedures with the risk of AKI. 
Critically sick neonates are at risk of having kidney 
injury, as they are commonly exposed to nephrotoxic 
medications and invasive therapeutic intervention 
such as assisted ventilation [25], [26], [27], [28]. 
In our study, neonates with AKI and lethal 
outcome have had severe SNAPPE 2 score. The high 
score level was significantly associated with the 
severity of the disease. Especially, very ill neonates 
with AKI and other co-morbid conditions were 
significantly associated with higher-level score and 
higher mortality. These findings correlate with the data 
presented in the study of Mortazavi et al. The mortality 
rate was significantly higher in neonates with difficult 
score level when admitted to the NICI, in whom further 
co-morbid conditions developed [29], [30], [31]. [32], 
[33]. 
In conclusion, acute kidney injury is a life-
threatening condition with still high mortality rate. The 
severity of the illness of hospitalised neonates in the 
intensive unit is estimated by SNAPPE 2 score. Also, 
the risk of mortality is estimated too, taking the fact 
that higher values of the score are associated with 
higher mortality. Appropriate treatment of neonates 
with severe kidney injury improves the outcome and 
reduces the mortality of the disease. 
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